Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Health Economics Review

Fig. 3

From: Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018–2019)

Fig. 3

Sensitivity analysis (Cost per patient, varying rates of successful TB treatment) (Minimal scenario: 2.2% increase of successful treatment at private PHC and hospitals, and 1.8% increase of successful treatment at public PHCs; Medium scenario: 4.3% increase of successful treatment at private PHC and hospitals, and 3.5% increase of successful treatment at public PHCs; Maximal scenario: 6.5% increase of successful treatment at private PHC and hospitals, and 5.3% increase of successful treatment at public PHCs.). *US$1 = 14,212 rupiah (Bank Indonesia, June 28, 2019)

Back to article page

Health Economics Review

ISSN: 2191-1991

Contact us